Thrombospondin-1 Restricts Interleukin-36γ-Mediated Neutrophilic Inflammation during Pseudomonas aeruginosa Pulmonary Infection

Pseudomonas aeruginosa pulmonary infection can lead to exaggerated neutrophilic inflammation and tissue destruction, yet host factors that regulate the neutrophilic response is not fully known. IL-36γ is a proinflammatory cytokine that dramatically increases in bioactivity following N-terminal processing by proteases. ABSTRACT Interleukin-36γ (IL-36γ), a member of the IL-1 cytokine superfamily, amplifies lung inflammation and impairs host defense during acute pulmonary Pseudomonas aeruginosa infection. To be fully active, IL-36γ is cleaved at its N-terminal region by proteases such as neutrophil elastase (NE) and cathepsin S (CatS). However, it remains unclear whether limiting extracellular proteolysis restrains the inflammatory cascade triggered by IL-36γ during P. aeruginosa infection. Thrombospondin-1 (TSP-1) is a matricellular protein with inhibitory activity against NE and the pathogen-secreted Pseudomonas elastase LasB—both proteases implicated in amplifying inflammation. We hypothesized that TSP-1 tempers the inflammatory response during lung P. aeruginosa infection by inhibiting the proteolytic environment required for IL-36γ activation. Compared to wild-type (WT) mice, TSP-1-deficient (Thbs1−/−) mice exhibited a hyperinflammatory response in the lungs during P. aeruginosa infection, with increased cytokine production and an unrestrained extracellular proteolytic environment characterized by higher free NE and LasB, but not CatS activity. LasB cleaved IL-36γ proximally to M19 at a cleavage site distinct from those generated by NE and CatS, which cleave IL-36γ proximally to Y16 and S18, respectively. N-terminal truncation experiments in silico predicted that the M19 and the S18 isoforms bind the IL-36R complex almost identically. IL-36γ neutralization ameliorated the hyperinflammatory response and improved lung immunity in Thbs1−/− mice during P. aeruginosa infection. Moreover, administration of cleaved IL-36γ induced cytokine production and neutrophil recruitment and activation that was accentuated in Thbs1−/− mice lungs. Collectively, our data show that TSP-1 regulates lung neutrophilic inflammation and facilitates host defense by restraining the extracellular proteolytic environment required for IL-36γ activation. IMPORTANCE Pseudomonas aeruginosa pulmonary infection can lead to exaggerated neutrophilic inflammation and tissue destruction, yet host factors that regulate the neutrophilic response are not fully known. IL-36γ is a proinflammatory cytokine that dramatically increases in bioactivity following N-terminal processing by proteases. Here, we demonstrate that thrombospondin-1, a host matricellular protein, limits N-terminal processing of IL-36γ by neutrophil elastase and the Pseudomonas aeruginosa-secreted protease LasB. Thrombospondin-1-deficient mice (Thbs1−/−) exhibit a hyperinflammatory response following infection. Whereas IL-36γ neutralization reduces inflammatory cytokine production, limits neutrophil activation, and improves host defense in Thbs1−/− mice, cleaved IL-36γ administration amplifies neutrophilic inflammation in Thbs1−/− mice. Our findings indicate that thrombospondin-1 guards against feed-forward neutrophilic inflammation mediated by IL-36γ in the lung by restraining the extracellular proteolytic environment.

[1]  A. Delmas,et al.  Imaging of extracellular cathepsin S activity by a selective near infrared fluorescence substrate-based probe. , 2019, Biochimie.

[2]  J. Kos,et al.  Cysteine Cathepsins in Tumor-Associated Immune Cells , 2019, Front. Immunol..

[3]  A. Oliver,et al.  Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections , 2019, Clinical Microbiology Reviews.

[4]  Richard A. Stanton,et al.  Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015 , 2019, Emerging infectious diseases.

[5]  J. Wenzel,et al.  Interleukin-36 in Infectious and Inflammatory Skin Diseases , 2019, Front. Immunol..

[6]  T. Kohler,et al.  Contribution of Human Thrombospondin-1 to the Pathogenesis of Gram-Positive Bacteria , 2019, Journal of Innate Immunity.

[7]  Janet S. Lee,et al.  Platelets inhibit apoptotic lung epithelial cell death and protect mice against infection-induced lung injury , 2019, Blood advances.

[8]  C. Calfee,et al.  Phenotypes in acute respiratory distress syndrome: moving towards precision medicine , 2019, Current opinion in critical care.

[9]  T. Standiford,et al.  Overlapping Roles for Interleukin-36 Cytokines in Protective Host Defense against Murine Legionella pneumophila Pneumonia , 2018, Infection and Immunity.

[10]  A. Jamieson,et al.  Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System , 2018, Front. Immunol..

[11]  Seamus J. Martin,et al.  Extracellular Neutrophil Proteases Are Efficient Regulators of IL-1, IL-33, and IL-36 Cytokine Activity but Poor Effectors of Microbial Killing. , 2018, Cell reports.

[12]  Seamus J. Martin,et al.  Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases , 2018, Cell Death & Disease.

[13]  Janet S. Lee,et al.  Thrombospondin-1 protects against pathogen-induced lung injury by limiting extracellular matrix proteolysis. , 2018, JCI insight.

[14]  William A. Mattingly,et al.  Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  T. Standiford,et al.  Interleukin-36γ and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2 , 2017, PLoS pathogens.

[16]  Yibing Yin,et al.  IL‐36 induces cytokine IL‐6 and chemokine CXCL8 expression in human lung tissue cells: Implications for pulmonary inflammatory responses , 2017, Cytokine.

[17]  M. Rybak,et al.  Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors. , 2017, Diagnostic microbiology and infectious disease.

[18]  A. Alase,et al.  Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ , 2017, Proceedings of the National Academy of Sciences.

[19]  Dima Kozakov,et al.  New additions to the ClusPro server motivated by CAPRI , 2017, Proteins.

[20]  B. Kazmierczak,et al.  Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection , 2017, Journal of Innate Immunity.

[21]  T. Standiford,et al.  IL-36γ is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumonia , 2017, Mucosal Immunology.

[22]  Dima Kozakov,et al.  The ClusPro web server for protein–protein docking , 2017, Nature Protocols.

[23]  Janet S. Lee,et al.  IL-17 Receptor Signaling in the Lung Epithelium Is Required for Mucosal Chemokine Gradients and Pulmonary Host Defense against K. pneumoniae. , 2016, Cell host & microbe.

[24]  J. Ybe,et al.  Structural and Functional Attributes of the Interleukin-36 Receptor* , 2016, The Journal of Biological Chemistry.

[25]  Anders Larsson,et al.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.

[26]  Seamus J. Martin,et al.  Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines. , 2016, Cell reports.

[27]  Bill B. Chen,et al.  Thrombospondin-1 restrains neutrophil granule serine protease function and regulates the innate immune response during Klebsiella pneumoniae infection , 2014, Mucosal Immunology.

[28]  E. Sundberg,et al.  Molecular Determinants of Agonist and Antagonist Signaling through the IL-36 Receptor , 2014, The Journal of Immunology.

[29]  G. Taraboletti,et al.  Current understanding of the thrombospondin-1 interactome. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[30]  J. Gudjonsson,et al.  IL-36 Promotes Myeloid Cell Infiltration, Activation, and Inflammatory Activity in Skin , 2013, The Journal of Immunology.

[31]  Feng Zhao,et al.  Protein threading using context-specific alignment potential , 2013, Bioinform..

[32]  Robert E Black,et al.  Global burden of childhood pneumonia and diarrhoea , 2013, The Lancet.

[33]  Jian Peng,et al.  Template-based protein structure modeling using the RaptorX web server , 2012, Nature Protocols.

[34]  Jian Peng,et al.  A conditional neural fields model for protein threading , 2012, Bioinform..

[35]  J. Lawler,et al.  Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. , 2012, Cold Spring Harbor perspectives in medicine.

[36]  M. Sweetwyne,et al.  Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms. , 2012, Matrix biology : journal of the International Society for Matrix Biology.

[37]  B. Kazmierczak,et al.  Innate immune responses to Pseudomonas aeruginosa infection. , 2011, Microbes and infection.

[38]  H. Dinh,et al.  IL-36R ligands are potent regulators of dendritic and T cells. , 2011, Blood.

[39]  C. Gabel,et al.  Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity , 2011, The Journal of Biological Chemistry.

[40]  P. Avila,et al.  Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells. , 2011, American journal of respiratory cell and molecular biology.

[41]  Stephen R Comeau,et al.  Achieving reliability and high accuracy in automated protein docking: Cluspro, PIPER, SDU, and stability analysis in CAPRI rounds 13–19 , 2010, Proteins.

[42]  C. Watts,et al.  Diverse regulatory roles for lysosomal proteases in the immune response , 2009, European journal of immunology.

[43]  Nicolas Lützner,et al.  Quantifying Cathepsin S Activity in Antigen Presenting Cells Using a Novel Specific Substrate* , 2008, Journal of Biological Chemistry.

[44]  Igor Rudan,et al.  Epidemiology and etiology of childhood pneumonia. , 2008, Bulletin of the World Health Organization.

[45]  A. Rodloff,et al.  Acute Respiratory Distress Syndrome and Pneumonia: A Comprehensive Review of Clinical Data , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  M. Laan,et al.  Neutrophils, interleukin-17A and lung disease , 2005, European Respiratory Journal.

[47]  J. Sims,et al.  Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-κB and MAPKs* , 2004, Journal of Biological Chemistry.

[48]  R. Maki,et al.  Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL1R-rp2) , 1996, Journal of Neuroimmunology.

[49]  P. Bornstein,et al.  Diversity of Function Is Inherent in Matricellular Proteins: an Appraisal of Thrombospondin I , 1995 .

[50]  P. Bornstein,et al.  Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. , 1991, The Journal of biological chemistry.

[51]  M. Iruela-Arispe,et al.  Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Silverstein,et al.  Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. , 1987, The Journal of clinical investigation.

[53]  J. Lawler The structural and functional properties of thrombospondin. , 1986, Blood.

[54]  D. Mosher,et al.  Localization of thrombospondin in clots formed in situ. , 1985, Blood.

[55]  L. Westrick,et al.  Incorporation of thrombospondin into fibrin clots. , 1985, The Journal of biological chemistry.

[56]  R. Silverstein,et al.  Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. , 1985, The Journal of clinical investigation.

[57]  R. Silverstein,et al.  Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator. , 1984, The Journal of clinical investigation.

[58]  E. Jaffe,et al.  Thrombospondin is the endogenous lectin of human platelets , 1982, Nature.

[59]  R. Maki,et al.  Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2). , 1996, Journal of neuroimmunology.

[60]  E. Jaffe,et al.  Monocytes and macrophages synthesize and secrete thrombospondin. , 1985, Blood.